Bambusa's lead product candidate, BBT001 is a next-generation long-acting bispecific antibody targeting two clinically and commercially validated targets, IL-4Rα and IL-31 for the treatment of atopic ...

Schools in Karnataka have registered a pass percentage of 99.77% in the Indian Certificate of Secondary Education Examination ...

The Big 12 Conference announced the 2026 Winter Academic All-Big 12 Teams on Thursday. A total of 691 student-athletes across ...

A total of 49 student-athletes from West Virginia University have been named to the 2026 Winter Academic All-Big 12 ...

Eli Lilly (LLY) has cemented its status as the world's leading pharmaceutical company as it produced a stellar set of Q1 2026 ...

Jamshedpur, Apr 30 (PTI) Shambhavi Tiwari, a resident of Jharkhand, scored 100 in all of her ‘best of four’ subjects in the Indian School Certificate (ISC) examination for class 12 conducted by the ...

RANCHI: Shambhavi Tewari from Jamshedpur has emerged as the national topper in the ISC Class 12 examinations, securing a ...

Celcuity (CELC) cautious Buy: gedatolisib upside hinges on Q2 2026 mutant cohort data in 2L HR+/HER2- breast cancer.

Trial Design, Dosing and Endpoints David Shapiro, M.D., Appointed to Board of Directors, Strengthening Clinical and Regulatory Expertise Cash and Securities of $222.8 Million at Quarter-End Provide ...

Proxygen announces two lead programs approaching clinical development, p300 and CDK12, addressing multiple cancer types Vienna, Austria, April 28, 2026 – Proxygen, a biotechnology company pioneering ...

Cochlear, CSL and Pro Medicus have been hard hit by disparate concerns, many of which investors suspect are structural rather ...

Rentosertib inhalation solution is the 13th program from Insilico's AI-driven pipeline to receive IND clearance, further demonstrating how Pharma.AI could reproducibly drive the discovery and ...